Showing 1 - 10 of 623
Flat fare flaw
Oped, Postbag, Published on 10/07/2025
» Re: "20-baht flat rate fare gets the nod", (BP, July 9).
Stepping up HIV fight
Oped, Editorial, Published on 30/06/2025
» The recent news of Gilead Sciences' groundbreaking new HIV preventative drug, Lenacapavir, offers a beacon of hope in the fight against HIV. With a remarkable 96% efficacy in reducing HIV infection and the convenience of only two injections per year, Lenacapavir holds the potential to be a true game-changer in the global effort to halt the transmission of HIV.
Life in a flu bubble
Oped, Postbag, Published on 22/05/2025
» Re: "Covid cases hit 33k last week", (BP, May 19) & "Covid alert as six die last week,' (BP, May 13).
Protectionism will not protect
Oped, Winnie Byanyima & Michael Marmot, Published on 16/05/2025
» As many Global North countries turn inwards, foreign assistance has become an easy target. The decimation of the US Agency for International Development (USAID) has dominated headlines, but the United Kingdom and many European countries have also cut their foreign-aid budgets. Policymakers in these countries view this spending as a form of charity and think that bolstering their economic and military might can deliver more benefits for more people.
Unite to solve neglected diseases
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
Aids fight cut short
Oped, Postbag, Published on 22/04/2025
» Re: "US funding cuts for Aids-HIV fight", (BP, April 17).
Covid's lessons have now all been forgotten
Oped, Antara Haldar, Published on 03/01/2025
» In December 2019, as the world was looking ahead to a new year, a novel virus was quietly spreading in China. Soon, the Covid-19 pandemic would bring the world to a grinding halt, forcing billions of people into unprecedented lockdowns and shuttering economies worldwide. Five years on, we are still grappling with the effects of this "grey rhino": a high-probability risk that was nonetheless neglected or ignored.
Nobody really wants to be a Nazi, but....
Oped, Gwynne Dyer, Published on 27/12/2024
» 'Alternativ fur Deutschland" (AfD) means "The Alternative for Germany", and the alternative on offer is fascism. Not actual Naziism, but the AfD uses fascist rhetoric and tactics to attract German voters. It has also attracted some improbable foreign admirers.
The world's babies need antibiotics
Oped, Glenda Gray, Published on 28/11/2024
» Over the last half-century, the number of children who die before reaching the age of five has fallen dramatically, from around 20 million in 1960 to 4.9 million in 2022, largely owing to the Expanded Programme on Immunisation (EPI). Established by the World Health Organization (WHO) in 1974, the EPI has been extraordinarily successful in providing the youngest people with access to vaccines, saving more than 150 million lives. But while such progress is worthy of celebration, there is still much work to do, because newborns comprise half of all deaths in children under five each year, many of which are caused by infection.
New PM talks big
Oped, Postbag, Published on 21/08/2024
» Re: "I will make every inch of Thailand fit ... ", (InQuote, Aug 19).